ENDRA Life Sciences Q1 EPS $(0.07), Inline

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is unchanged from the same period last year.

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is unchanged from the same period last year.

Total
0
Shares
Related Posts